Corrigendum to “Rationale and design of the HOME trial: A pragmatic randomized controlled trial of home-based human papillomavirus (HPV) self-sampling for increasing cervical cancer screening uptake and effectiveness in a U.S. healthcare system” [Contemp. Clin. Trials 64 (2018) 77–87]